Laboratory Test Detail

Last Updated: July 13, 2024 @ 9:13 am

5180

Herpes Simplex Virus 1/2 rRNA, TMA (NAAT)

Specimen:Collect:
  • Genital Swab in Aptima Kit-Multitest (Orange)

Also Acceptable:
  • Rectal Swab in Aptima Kit-Multitest (Orange)
Submit:
  • Genital Swab in Aptima Kit-Multitest (Orange). Submit Ambient.

Also Acceptable:
  • Rectal Swab in Aptima Kit-Multitest (Orange). Submit Ambient.
Rejection Criteria:
  • Samples collected in any transport media other than Aptima
    Samples collected after Aptima-tube expiration date
    Transport tubes with incorrect or missing swabs.
Stability:Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 1 Month(s); Incubated: Unacceptable
Methodology:
  • Target Amplified Nucleic Acid Probe
Performed:Mon-Fri
Reported:1-3 Day(s)
CPT Codes:
  • 87529x2
Interpretive Data:Please see report for interpretive data.

The Aptima Herpes Simplex Viruses 1 and 2 assay (Aptima HSV 1 and 2 assay) is an in vitro diagnostic nucleic acid amplification test (NAAT), using real time transcription mediated amplification (TMA), for the qualitative detection and differentiation of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) messenger RNA (mRNA) in clinician-collected swab specimens from anogenital skin lesions. The Aptima HSV 1 and 2 assay is intended for use as an aid in the diagnosis of HSV-1 and/or HSV-2 infections in symptomatic male and female patients.
Components:
  • 1161 - HSV 1 RNA
  • 1162 - HSV 2 RNA
  • 1188 - SOURCE
Print Friendly, PDF & Email

Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.